Literature DB >> 6440941

Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation.

S E Hall, M E Wastney, T M Bolton, J T Braaten, M Berman.   

Abstract

The kinetics of acetoacetate (A) and beta-hydroxybutyrate (B) have been studied following the injection as a pulse or continued infusion of [3-14C]acetoacetate (A*) or [14C]beta-hydroxybutyrate (B*) into six newly diagnosed, untreated, ketotic diabetic patients, ten obese subjects in the postabsorptive state, and the ten obese subjects after 1-2 weeks starvation (50 cal per day). Employing a compartmental model of acetoacetate and beta-hydroxybutyrate kinetics developed using CONSAM for normal subjects, the rate coefficients (Lij), rates of release of newly synthesized acetoacetate and beta-hydroxybutyrate into the blood (UA, UB), and fractional removal of each compound (FCRA and FCRB) were calculated. Ketone body release into blood (UA + UB) in diabetic subjects was threefold higher than normal (mean +/- SD, 208 +/- 118 versus 81 +/- 66 mumol min-1 m-2) and in obese subjects the rate increased on starvation from 171 +/- 70 to 569 +/- 286 mumol min-1 m-2. In each case most of the increase was in beta-hydroxybutyrate. The major change in diabetes and on starvation of the obese subjects was in the rate coefficient for removal of ketone bodies. Normally 0.168 +/- 0.109 min-1, it was 0.055 +/- 0.040 min-1 in the diabetic patients and fell from 0.066 +/- 0.040 to 0.027 +/- 0.019 min-1 in the obese subjects on starvation. In normal subjects, FCRA was similar to FCRB (0.226 +/- 0.142 versus 0.188 +/- 0.124 min-1). However, in diabetics, FCRA was 0.074 +/- 0.044 and FCRB was 0.050 +/- 0.034 min-1 and both were lower than normal. On starvation of obese subjects, FCRA fell from 0.199 +/- 0.047 to 0.089 +/- 0.035 min-1, whereas FCRB fell from 0.141 +/- 0.040 to 0.033 +/- 0.012 min-1. Therefore, the removal of beta-hydroxybutyrate was impaired more than that of acetoacetate in all patients. Our results confirm previous observations that ketosis is associated with high rates of ketogenesis and a decrease in fractional clearance. In addition, we found that in diabetes, obesity, and in obese subjects following starvation, most of the increased synthesis was in beta-hydroxybutyrate and that the clearance of beta-hydroxybutyrate decreased more than that of acetoacetate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440941

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  21 in total

1.  Dynamics of starvation in humans.

Authors:  Baojun Song; Diana M Thomas
Journal:  J Math Biol       Date:  2006-09-08       Impact factor: 2.259

2.  The Population Pharmacokinetics of D-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate.

Authors:  Vittal Shivva; Pete J Cox; Kieran Clarke; Richard L Veech; Ian G Tucker; Stephen B Duffull
Journal:  AAPS J       Date:  2016-02-18       Impact factor: 4.009

3.  Impact of Body Habitus on the Outcomes of Pediatric Patients With Diabetic Ketoacidosis.

Authors:  Brady S Moffett; Joseph Allen; Mahmood Khichi; Bonnie McCann-Crosby
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

4.  A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial.

Authors:  Étienne Myette-Côté; Hannah G Caldwell; Philip N Ainslie; Kieran Clarke; Jonathan P Little
Journal:  Am J Clin Nutr       Date:  2019-12-01       Impact factor: 7.045

5.  Decreased rate of ketone-body oxidation and decreased activity of D-3-hydroxybutyrate dehydrogenase and succinyl-CoA:3-oxo-acid CoA-transferase in heart mitochondria of diabetic rats.

Authors:  L Grinblat; L F Pacheco Bolaños; A O Stoppani
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

6.  Effect of insulin on ketone body clearance studied by a ketone body "clamp" technique in normal man.

Authors:  U Keller; M Lustenberger; W Stauffacher
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

Review 7.  Ketone body metabolism and cardiovascular disease.

Authors:  David G Cotter; Rebecca C Schugar; Peter A Crawford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-08       Impact factor: 4.733

Review 8.  Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes.

Authors:  Preeti Kanikarla-Marie; Sushil K Jain
Journal:  Free Radic Biol Med       Date:  2016-03-29       Impact factor: 7.376

9.  Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Magdalena Mazagova; Angela Horvath; Lirui Wang; Cristina Llorente; Nissi M Varki; Katharina Brandl; Samuel B Ho; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-23       Impact factor: 4.052

10.  Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects.

Authors:  Kieran Clarke; Kirill Tchabanenko; Robert Pawlosky; Emma Carter; M Todd King; Kathy Musa-Veloso; Manki Ho; Ashley Roberts; Jeremy Robertson; Theodore B Vanitallie; Richard L Veech
Journal:  Regul Toxicol Pharmacol       Date:  2012-05-03       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.